March 10 (Reuters) - The former CEO of Magellan Diagnostics pleaded guilty on Monday to a criminal charge related to a malfunction in the company's lead-testing devices that produced inaccurately ...

From 2013 until December 2017, Magellan Diagnostics of Billerica sold machines with a manufacturing defect that gave false negative readings. The three executives, including former Magellan chief ...

Ultimately, this has impacted Magellan shares. Magellan saw net retail outflows of $200 million and net institutional outflows of $300 million last month. This reverses a brief period of stability ...